Auvelity Dosage: The One-Dose Plan and What It Means for You

Most antidepressants come with an unspoken next step: if the first dose isn’t enough, the dose goes up. Auvelity (dextromethorphan-bupropion) is different, because for depression the label lists one maintenance dose and nothing above it.

That design comes from how the two ingredients behave together in your body. Your liver normally clears dextromethorphan fast, through an enzyme called CYP2D6, and bupropion slows that enzyme down. The Auvelity prescribing information shows how large that effect is: at steady state, dextromethorphan exposure builds to about 32 times its first-dose level when given with bupropion, compared with about 1.4 times without it. A pairing that powerful calls for a dose set with precision rather than one that drifts up and down.

The fixed dose has solid evidence behind it. In the phase 3 GEMINI trial of 327 adults with depression, the full twice-daily dose cut depression scores by 15.9 points versus 12.0 on placebo, and 39.5% reached remission at week 6 compared with 17.3%. The results are real, and the trial evidence is consistent.

But a medication with one dose leaves no room for slow dose changes, and at Siggy we believe the weeks after starting deserve close attention rather than a check-in months later. Knowing why the dose stays put, who takes one tablet instead of two, and what happens if it isn’t working makes those first weeks far less confusing. The single maintenance dose follows how the two drugs interact inside your body, not a shortcut in prescribing.

What This Page Covers

• The Standard Auvelity Schedule for Depression
• Why There Is Only One Maintenance Dose
• Who Takes One Tablet a Day Instead of Two
• What the Trials Show About Timing
• If Auvelity Isn’t Working at the Full Dose
• Missed Doses, Stopping, and Safety Checks
• How Siggy Thinks About Fixed-Dose Medications

The Standard Auvelity Schedule for Depression

For major depressive disorder in adults, the schedule is short. You take one 45 mg dextromethorphan/105 mg bupropion tablet each morning for 3 days. On day 4, you move to one tablet twice a day, at least 8 hours apart, and you don’t take more than two doses in a day.

A few rules come with it. Swallow the tablet whole, because the label says not to crush, split, or chew it. You can take it with or without food.

Before you start, the label asks your prescriber to check your blood pressure, screen for a personal or family history of bipolar disorder, and make sure you aren’t taking other products that contain bupropion or dextromethorphan.

You may see a second strength, 30 mg/105 mg, on newer labeling. That tablet is used in the separate titration schedule for agitation linked to Alzheimer’s disease, and it isn’t part of the standard depression schedule.

Why There Is Only One Maintenance Dose

Three features of the drug explain why twice daily is both the target and the ceiling.

First, the boost is steep. Bupropion’s CYP2D6 blockade roughly triples dextromethorphan’s half-life, to about 22 hours, and steady levels of both drugs arrive within about 8 days of twice-daily dosing.

Second, the math isn’t linear. The label’s pharmacokinetics section notes that when dextromethorphan is given with bupropion, raising its dose raises blood levels more than proportionally. A bigger tablet wouldn’t mean a proportionally bigger effect, and it could mean a much bigger exposure.

Third, bupropion carries a dose-related seizure risk. The label reports a seizure rate of about 0.1% at 300 mg a day of sustained-release bupropion and about 0.4% at 400 mg a day. Auvelity’s full dose delivers 210 mg of bupropion a day, which keeps it below those levels.

The trial record points the same way. Both pivotal depression trials tested one tablet twice daily, so that’s the dose with outcome data behind it.

Who Takes One Tablet a Day Instead of Two

Some people clear dextromethorphan more slowly, so one tablet gives them exposure closer to what two tablets give others. The FDA label’s dosing section sets these limits for depression.

Situation	Auvelity Dose for Depression
Most adults	1 tablet each morning for 3 days, then twice daily
Moderate kidney impairment (eGFR 30 to 59)	1 tablet each morning, maximum
Known CYP2D6 poor metabolizer	1 tablet each morning, maximum
Taking a strong CYP2D6 inhibitor	1 tablet each morning, maximum
Severe kidney impairment	Not recommended
Severe liver impairment	Not recommended

Mild or moderate liver impairment doesn’t require a dose change, according to the label. Strong CYP2B6 inducers, a group of drugs that speed up bupropion’s metabolism, lower levels of both ingredients, so the label advises avoiding them. Your pharmacist can tell you whether anything you take falls into one of these groups.

What the Trials Show About Timing

Auvelity’s evidence stands out for how early the difference appeared. In GEMINI, the Auvelity group improved more than placebo at every time point, starting at week 1, and 54.0% responded by week 6 versus 34.0% on placebo.

The comparison against bupropion alone matters too. In the ASCEND trial against bupropion, 46.5% of people on Auvelity reached remission at week 6 compared with 16.2% on the same 105 mg twice-daily bupropion dose. That result suggests the dextromethorphan is doing real work, not just riding along. A Stanford psychopharmacology dosing review adds a caveat: ASCEND used a low bupropion dose, so how Auvelity compares with more typical bupropion doses of 300 to 450 mg a day is still unclear.

Both trials had limits. They lasted 6 weeks, were sponsored by the manufacturer, and ASCEND’s efficacy analysis included only 80 people. A 2023 review of long-term data describes open-label studies of up to 12 to 15 months in which improvement held, though open-label designs can’t rule out placebo effects.

Side effects tend to show up early. In GEMINI, dizziness affected 16% of people on Auvelity versus 6% on placebo, and 4% stopped because of side effects versus none on placebo.

If Auvelity Isn’t Working at the Full Dose

With most antidepressants, a partial response leads to a dose increase. With Auvelity, that option doesn’t exist, so the conversation with your prescriber looks different.

It usually starts with a few checks:

• Are you taking both doses every day, at least 8 hours apart?
• Have you started a new medication that changes how Auvelity is processed?
• Has it been long enough, given that steady levels take about a week to reach?

If those check out and depression isn’t lifting, the next steps are switching to a different medication or adding a treatment, and those decisions belong with a licensed prescriber. What you shouldn’t do is add over-the-counter dextromethorphan or extra bupropion on your own. The label warns that seizure risk rises with dose, and MedlinePlus drug guidance notes that dextromethorphan appears in many cough and cold products.

Missed Doses, Stopping, and Safety Checks

If you miss a dose, MedlinePlus advises skipping it and taking the next one on schedule, without doubling up. Stopping suddenly isn’t recommended either, because it can bring mood changes, irritability, dizziness, trouble sleeping, and other symptoms, so any plan to stop should go through your prescriber.

A few safety points matter throughout treatment:

• Blood pressure should be checked periodically, since bupropion can raise it.
• Taking Auvelity with an SSRI or tricyclic antidepressant raises the risk of serotonin syndrome, according to the label.
• Alcohol should be minimized or avoided.
• The label advises against Auvelity in pregnancy and against breastfeeding during treatment and for 5 days after the last dose.

Like all antidepressants, Auvelity carries a boxed warning about suicidal thoughts in people 24 and younger, especially early on. If you have a seizure, thoughts of harming yourself, or a sudden change in mood or behavior, call 911 or call or text 988 right away.

How Siggy Thinks About Fixed-Dose Medications

“I’d be comfortable using AI as long as a real doctor is reviewing it.” With a medication that has one dose, that review matters even more, because once you start, the main question left is how that dose is landing for you.

Auvelity is one of the medications a Siggy prescriber can consider after reviewing your intake. A real doctor reviews every treatment plan before anything is prescribed. With a fixed dose, what you notice is the most useful information: early dizziness, sleep changes, blood pressure readings, and mood shifts. Jotting those down as they come up gives your prescriber a clear record to work from at each follow-up, instead of a best guess from memory.

Auvelity trades dose flexibility for a pairing that reaches steady levels fast and showed early benefit in trials, and that tradeoff works best when the first few weeks get close attention. For a contrast with an antidepressant that does get adjusted step by step, see our guide to how doctors choose a Lexapro dose. If you’re considering a medication plan for depression or anxiety, Siggy’s free, anonymous intake takes no name, email, or login, and you get a consult summary and a downloadable report you can share with any clinician.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.